Related content

Tyrosine kinase inhibition in acute myeloid leukemia

By Altman Jessica K.   Szilard Amy K.   Platanias Leonidas C.  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1351-1352

Informa Healthcare

Access to resources Recommend Favorite

Expression and clinical significance of vascular endothelial growth factor and fmsrelated tyrosine kinase 1 in colorectal cancer

By        

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2414-2418

Spandidos Publications

Access to resources Recommend Favorite

Overexpression of serine/threonineprotein kinase-1 in pancreatic cancer tissue: Serine/threonine-protein kinase-1 knockdown increases the chemosensitivity of pancreatic cancer cells

By                

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 475-481

Spandidos Publications

Access to resources Recommend Favorite

The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: Biology and therapeutic relevance

By Gross J.M.  

Cancer and Metastasis Reviews, Vol. 22, Iss. 4, 2003-12 ,pp. : 327-336

Springer Publishing Company

Access to resources Recommend Favorite

Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 31-49

Bentham Science Publishers

Access to resources Recommend Favorite